Shanghai MicroPort Endovascular MedTech Group Co Ltd
SSE:688016

Watchlist Manager
Shanghai MicroPort Endovascular MedTech Group Co Ltd Logo
Shanghai MicroPort Endovascular MedTech Group Co Ltd
SSE:688016
Watchlist
Price: 96.95 CNY -1.27% Market Closed
Market Cap: ¥12B

Wall Street
Price Targets

Price Targets Summary
Shanghai MicroPort Endovascular MedTech Group Co Ltd

Wall Street analysts forecast Shanghai MicroPort Endovascular MedTech Group Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Shanghai MicroPort Endovascular MedTech Group Co Ltd is 131.6 CNY with a low forecast of 105.04 CNY and a high forecast of 157.5 CNY.

Lowest
Price Target
105.04 CNY
8% Upside
Average
Price Target
131.6 CNY
36% Upside
Highest
Price Target
157.5 CNY
62% Upside
Shanghai MicroPort Endovascular MedTech Group Co Ltd Competitors:
Price Targets
AHCO
Adapthealth Corp
33% Upside
VRTX
Vertex Pharmaceuticals Inc
12% Upside

Revenue
Forecast

33% / Year
Past Growth
23% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
33% / Year
Past Growth
23% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

For the last 7 years the compound annual growth rate for Shanghai MicroPort Endovascular MedTech Group Co Ltd's revenue is 33%. The projected CAGR for the next 3 years is 23%.

Operating Income
Forecast

35% / Year
Past Growth
19% / Year
Estimated Growth
Estimates Accuracy
1%
Average Beat
35% / Year
Past Growth
19% / Year
Estimated Growth
Estimates Accuracy
1%
Average Beat

For the last 7 years the compound annual growth rate for Shanghai MicroPort Endovascular MedTech Group Co Ltd's operating income is 35%. The projected CAGR for the next 3 years is 19%.

Net Income
Forecast

34% / Year
Past Growth
20% / Year
Estimated Growth
Estimates Accuracy
-11%
Average Miss
34% / Year
Past Growth
20% / Year
Estimated Growth
Estimates Accuracy
-11%
Average Miss

For the last 7 years the compound annual growth rate for Shanghai MicroPort Endovascular MedTech Group Co Ltd's net income is 34%. The projected CAGR for the next 3 years is 20%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Shanghai MicroPort Endovascular MedTech Group Co Ltd's stock price target?
Price Target
131.6 CNY

According to Wall Street analysts, the average 1-year price target for Shanghai MicroPort Endovascular MedTech Group Co Ltd is 131.6 CNY with a low forecast of 105.04 CNY and a high forecast of 157.5 CNY.

What is Shanghai MicroPort Endovascular MedTech Group Co Ltd's Revenue forecast?
Projected CAGR
23%

For the last 7 years the compound annual growth rate for Shanghai MicroPort Endovascular MedTech Group Co Ltd's revenue is 33%. The projected CAGR for the next 3 years is 23%.

What is Shanghai MicroPort Endovascular MedTech Group Co Ltd's Operating Income forecast?
Projected CAGR
19%

For the last 7 years the compound annual growth rate for Shanghai MicroPort Endovascular MedTech Group Co Ltd's operating income is 35%. The projected CAGR for the next 3 years is 19%.

What is Shanghai MicroPort Endovascular MedTech Group Co Ltd's Net Income forecast?
Projected CAGR
20%

For the last 7 years the compound annual growth rate for Shanghai MicroPort Endovascular MedTech Group Co Ltd's net income is 34%. The projected CAGR for the next 3 years is 20%.

Back to Top